FDA.reportPublic FDA data

besifloxacin 6 MG/ML Ophthalmic Suspension [Besivance]

RxCUI
850309
RxNorm name
besifloxacin 6 MG/ML Ophthalmic Suspension [Besivance]
Display name
besifloxacin 6 MG/ML Ophthalmic Suspension [Besivance]
Full name
besifloxacin 6 MG/ML Ophthalmic Suspension [Besivance]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BesivanceBESIFLOXACINSportpharm LLC80bf4981-4f86-4d25-83a5-7d5dfe0b22e02026-07-23Warnings, Adverse reactionsExact identifier
rxcui: 850309
BesivanceBESIFLOXACINBausch & Lomb Incorporateda3e6d688-7e5e-4ca3-b27e-79756c322a322024-07-03Warnings, Adverse reactionsExact identifier
rxcui: 850309

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a3e6d688-7e5e-4ca3-b27e-79756c322a32Besivance 0.6 % Ophthalmic Suspension [PSN] · besifloxacin 6 MG/ML Ophthalmic Suspension [Besivance] [SBD] · Besivance 0.6 % Ophthalmic Suspension [SY] · Besivance 6 MG/ML Ophthalmic Suspension [SY]420These highlights do not include all the information needed to use BESIVANCE safely and effectively. See full prescribing information for BESIVANCE. BESIVANCE ® (besifloxacin ophthalmic suspension), for topical ophthalmic use Initial U.S. Approval: 200920240703
c326263e-4b55-41b6-b862-c970668669ecBesivance 0.6 % Ophthalmic Suspension [PSN] · besifloxacin 6 MG/ML Ophthalmic Suspension [Besivance] [SBD] · Besivance 0.6 % Ophthalmic Suspension [SY] · Besivance 6 MG/ML Ophthalmic Suspension [SY]41These highlights do not include all the information needed to use Besivance safely and effectively. See full prescribing information for Besivance. Besivance TM (besifloxacin ophthalmic suspension) 0.6% Sterile topical ophthalmic drops Initial U.S. Approval: 200920090401